Pure Bioscience - Securities Registration (section 12(b)) (8-A12B)
2008年3月31日 - 9:27PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-A
FOR REGISTRATION OF
CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION
12(b) or (g) OF THE
SECURITIES EXCHANGE ACT
OF 1934
Pure Bioscience
|
(Exact name of registrant as specified in its charter)
|
State of California
|
33-0530289
|
(State of incorporation or organization)
|
(I.R.S. Employer Identification No.)
|
1725 Gillespie Way
El Cajon, CA 92020
|
(Address of principal executive offices) (Zip Code)
|
Securities to be
registered pursuant to Section 12(b) of the Act:
|
|
Title of Each Class
to be Registered
|
Exchange
|
Common Stock
|
NASDAQ CAPITAL MARKET
|
If this form relates to the
registration of a class of securities pursuant to Section 12(b) of the Exchange Act and
is effective pursuant to General Instruction A.(c), check the following box. [X]
If this form relates to the
registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is
effective pursuant to General Instruction A.(d), check the following box. [_]
Securities Act registration
statement file number to which this form relates: NA (if applicable)
Securities to be registered pursuant
to Section 12(g) of the Exchange Act: None.
INFORMATION REQUIRED
IN REGISTRATION STATEMENT
Item 1. Description of
Registrants Securities to be Registered:
Pure Bioscience is authorized to
issue up to 50,000,000 shares of our no par value common stock. Each share is entitled to
one vote on matters submitted to a vote of the shareholders. There is no cumulative voting
of the common stock. The common stock shares have no redemption provisions nor any
preemptive rights. We are also authorized to issue up to 5,000,000 shares of preferred
stock, the rights and preferences of which may be set from time to time prior to issuance
by the Board of Directors.
Item 2. Exhibits
3.1 (1)
|
-- Articles of Incorporation, Articles of Amendment and Bylaws
|
3.1.1 (2)
|
-- Articles of Amendment dated March 11, 2002
|
4.3 (1)
|
-- Form of common stock Certificate
|
(1)
|
Incorporated
by reference from Form SB-2 registration statement SEC File #333-00434 effective
August 8, 1996
|
(2)
|
Incorporated
by reference from the Annual Report on Form 10KSB for the fiscal year ended July 31,
2002 filed on October 29, 2003
|
SIGNATURE
Pursuant
to the requirements of Section 12 of the Securities Exchange Act of 1934, the Registrant
has duly caused this amendment to its registration statement on Form 8-A to be signed on
its behalf by the undersigned, thereto duly authorized.
|
|
Date: March 31, 2008
|
PURE BIOSCIENCE
By:
/s/ Michael L. Krall
Michael L. Krall, President
|
PURE Bioscience (PK) (USOTC:PURE)
過去 株価チャート
から 6 2024 まで 7 2024
PURE Bioscience (PK) (USOTC:PURE)
過去 株価チャート
から 7 2023 まで 7 2024
Real-Time news about PURE Bioscience Inc (PK) (その他OTC): 0 recent articles
その他のPure Bioscienceニュース記事